Teriparatide treatment in severe osteoporosis – a controlled 10-year follow-up study

BACKGROUND: Teriparatide was the first anabolic agent recommended for the treatment of osteoporosis. Long-term real-world, controlled studies are not available. The purpose was to evaluate the long-term effects of treatment with teriparatide on fractures and Health Related Quality of Life in subject...

Descripción completa

Detalles Bibliográficos
Autores principales: Kontogeorgos, Georgios, Krantz, Emily, Trimpou, Penelope, Laine, Christine M., Landin-Wilhelmsen, Kerstin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686095/
https://www.ncbi.nlm.nih.gov/pubmed/36424580
http://dx.doi.org/10.1186/s12891-022-05987-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686095/
https://www.ncbi.nlm.nih.gov/pubmed/36424580
http://dx.doi.org/10.1186/s12891-022-05987-2

Ejemplares similares